李建萍, 张小清, 谢明, 左克强, 黄存嫦. 甲状腺癌组织端粒酶激活与p16基因失活的研究[J]. 中国肿瘤临床, 2006, 33(12): 690-692.
引用本文: 李建萍, 张小清, 谢明, 左克强, 黄存嫦. 甲状腺癌组织端粒酶激活与p16基因失活的研究[J]. 中国肿瘤临床, 2006, 33(12): 690-692.
Li Jianping, Zhang XiaoQing, Xie Ming, Zuo Keqiang, Huang Cunchang. The Association between Activation of Telomerase and Inactivation of the p16 Gene in Thyroid Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(12): 690-692.
Citation: Li Jianping, Zhang XiaoQing, Xie Ming, Zuo Keqiang, Huang Cunchang. The Association between Activation of Telomerase and Inactivation of the p16 Gene in Thyroid Cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(12): 690-692.

甲状腺癌组织端粒酶激活与p16基因失活的研究

The Association between Activation of Telomerase and Inactivation of the p16 Gene in Thyroid Cancer

  • 摘要: 目的 :探讨甲状腺癌细胞增殖、分化与端粒酶激活及抑癌基因p16失活(缺失突变)之间可能存在的联系。 方法 :应用TRAP、多重PCR、免疫组化法检测42例甲状腺癌与16例癌旁组织端粒酶活性、p16基因外显子2缺失、p16蛋白表达。 结果 :甲状腺癌组端粒酶活性90.48%,高于癌旁组织(P<0.01);甲状腺癌p16基因外显子2纯合缺失率28.57%,相应癌旁组未检出(P<0.01);甲状腺癌p16蛋白表达缺失率40.48%,高于癌旁组(P<0.05);甲状腺癌p16蛋白表达缺失率高于p16基因外显子2缺失率。 结论 :端粒酶激活与p16基因失活以及p16蛋白表达下调可能是甲状腺癌变过程中的重要分子事件,甲状腺癌中p16基因失活可能是端粒酶激活的一种途径。

     

    Abstract: Objective :To study the relationship between telomerase activity and inactivation(deletion mutation) of the p16 gene in thyroid cancer. Methods :Telomerase activation was detectedwith TRAP, p16 gene deletion with multiplex PCR and p16 protein expression with an immunochemicaltechnique in 42 cases of thyroid cancer and 16 normal tissues. Results :Telomerase activity was signifi-cantly increased in cancer tissues (90.48%) compared to normal tissues (P<0.01). The deletion rate ofp16 exon 2 was 28.57% in thyroid cancer, and this deletion was not detected in any tumor-adjacenttissues (P<0.01). P16 protein expression was decreased in thyroid cancer compared to normal tissue(P<0.05). Ablation of p16 protein expression occurred 40.48% more often than deletion of p16 exon 2. Conclusion :The activation of telomerase, deletion of the p16 gene, and ablation of p16 protein ex-pression might occur early in thyroid cancer and play a critical role in tumor development. In humanthyroid cancer loss of the p16 gene may activate telomerase.

     

/

返回文章
返回